Guidelines for the Treatment of MDS
Rami Komrokji, MD, discusses his approach to treatment in patients with myelodysplastic syndrome, while being mindful of recommended guidelines.
Read More
Individualized Treatment for MDS
The panel of leukemia experts highlight the importance of individualized treatments for patients with myelodysplastic syndrome.
Read More
Staging Models in Diagnosis and Risk Assessment of MDS
Rami Komrokji, MD, and Gail Roboz, MD, discuss the importance of staging models in the diagnosis and routine assessment of patients with myelodysplastic syndrome.
Read More
The Impact of Mutational Status on Treatment Considerations for MDS
James Foran, MD; Azra Raza, MD; and Gail Roboz, MD, discuss how mutation status in myelodysplastic syndrome may impact treatment considerations.
Read More
Clinical Considerations in the Diagnosis of Patients with MDS
Rami Komrokji, MD, of the H. Lee Moffitt Cancer Center & Research Institute, discusses the importance of examining a patient’s complete blood count, nutritional status and bone marrow when considering a diagnosis of myelodysplastic syndrome.
Read More
Myelodysplastic Syndrome Diagnosis and Risk Assessment
Gail Roboz, MD; Azra Raza, MD; and Amy DeZern, MD, MHS, discuss the clinical considerations and risk assessments inherent to a diagnosis of myelodysplastic syndrome.
Read More